Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Cytrans Granules

K-Number: K192597 · 2020-08-17

Decision Date2020-08-17
Product CodeLYC
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

Cytrans Granules is a medical device manufactured by GC America, Inc.. It received FDA 510(k) clearance on 2020-08-17 under approval number K192597. The device is classified under product code LYC. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Cytrans Granules?

Cytrans Granules is a medical device that received FDA 510(k) clearance on 2020-08-17. It is manufactured by GC America, Inc.. The 510(k) number is K192597.

When was Cytrans Granules approved by the FDA?

Cytrans Granules received FDA 510(k) clearance on 2020-08-17, under approval number K192597.

What company makes Cytrans Granules?

Cytrans Granules is manufactured by GC America, Inc..

What is the FDA product code for Cytrans Granules?

The FDA product code for Cytrans Granules is LYC.

Other Devices by GC America, Inc.

View all 21 devices →

Related Devices (Code: LYC)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.